Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 4:52-57 (2007)
© 2007 The American Thoracic Society
doi: 10.1513/pats.200605-129JG

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyle, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, M. P.

Strategies for Identifying Modifier Genes in Cystic Fibrosis

Michael P. Boyle

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Michael P. Boyle, M.D., The Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th floor, Baltimore, MD 21205. E-mail: mboyle{at}jhmi.edu

ABSTRACT

Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.

Key Words: cystic fibrosis • genotype • modifier • phenotype • transforming growth factor ß




This article has been cited by other articles:


Home page
J. Physiol.Home page
E. Bonvin, P. Le Rouzic, J.-F. Bernaudin, C.-H. Cottart, C. Vandebrouck, A. Crie, T. Leal, A. Clement, and M. Bonora
Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice
J. Physiol., July 1, 2008; 586(13): 3231 - 3243.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P de Bie, P Muller, C Wijmenga, and L W J Klomp
Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes
J. Med. Genet., November 1, 2007; 44(11): 673 - 688.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. P. Boyle
Adult Cystic Fibrosis
JAMA, October 17, 2007; 298(15): 1787 - 1793.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Thoracic Society.